Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
暂无分享,去创建一个
[1] C. Drachenberg,et al. Thymoglobulin Dose Optimization for Induction Therapy in High Risk Kidney Transplant Recipients , 2008, Transplantation.
[2] A. Langnas,et al. Randomized Trial of Single-Dose Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation: An Interim Report , 2008, Transplantation.
[3] W. Winkelmayer,et al. Comparison of two dosages of thymoglobulin used as a short‐course for induction in kidney transplantation , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[4] Tutut Herawan,et al. Computational and mathematical methods in medicine. , 2006, Computational and mathematical methods in medicine.
[5] R. Stratta,et al. Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage. , 2005, Transplantation proceedings.
[6] F. Delmonico,et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1 , 2003, Transplantation.
[7] Paulo Fontes,et al. Tolerogenic immunosuppression for organ transplantation , 2003, The Lancet.
[8] E. Woodle,et al. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients , 2002, Transplantation.
[9] T. Howard,et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. , 2002, Transplantation.
[10] J. Revillard,et al. MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1 , 2001, Transplantation.
[11] M. Schnitzler,et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.
[12] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[13] H. E. Hansen,et al. The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.
[14] K. Lamborn,et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. , 1998, Transplantation.
[15] M. Schnitzler,et al. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. , 1997, Transplantation.
[16] T. Howard,et al. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. , 1997, Journal of the American Society of Nephrology : JASN.
[17] Robert Kerchner,et al. Interim Report , 1996 .